AG490 (Tyrphostin AG490) is a selective inhibitor of EGF receptor tyrosine kinase with an IC50 values of 2 and 13.5 μM for EGFR and ErbB2 respectively. AG490 is also a JAK3/STAT, JAK3/AP-1 and JAK3/MAPK signaling pathway inhibitor and also blocks JAK3 autophosphorylation. AG-490 significantly inhibits the constitutive activation of Stat3 in MOPC, MPC11, and S194 cells, leading to dramatic dose-dependent apoptosis. AG-490 (100 μM) inhibits Akt phosphorylation, inhibits the activation of nuclear factor-κB, and causes the activation of GSK-3β, leading to the reduction of c-Myc. AG-490 (50 μM) can induce apoptosis of imatinib-resistant BaF3 cells expressing T315I and E255K mutants of Bcr-Abl.
Int J Ophthalmol. 2022 Apr 18;15(4):554-559.
Leptin activates the JAK/STAT pathway to promote angiogenesis in RF/6A cells in vitro
AG490 purchased from AbMole
Int J Ophthalmol. 2022 Apr 18;15(4):554-559.
Leptin activates the JAK/STAT pathway to promote angiogenesis in RF/6A cells in vitro
AG490 purchased from AbMole
Int Immunopharmacol. 2023 Feb;115:109693.
JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway
AG490 purchased from AbMole
J Tradit Chin Med. 2019 April 15;39(2): 181-190.
Efficacy of Zhonglun'a-decoction-containing serum on fibroblast-like synoviocyte apoptosis in rats with collagen-induced arthritis via inhibiting Janus kinase/signal transducer and activator of transcription signaling pathway.
AG490 purchased from AbMole
Med Sci Monit. 2018 Sep 8;24:6255-6263.
Inhibition of JAK2/STAT3 Signaling Pathway Suppresses Proliferation of Burkitt's Lymphoma Raji Cells via Cell Cycle Progression, Apoptosis, and Oxidative Stress by Modulating HSP70.
AG490 purchased from AbMole
Nutr Res. 2018 Mar 18.
Folic acid supplementation repressed hypoxia-induced inflammatory response via ROS and JAK2/STAT3 pathway in human pro-myelomonocytic cells
AG490 purchased from AbMole
Int J Mol Med. 2017 Feb;39(2):307-316.
Matrine induces the apoptosis of fibroblast-like synoviocytes derived from rats with collagen-induced arthritis by suppressing the activation of the JAK/STAT signaling pathway
AG490 purchased from AbMole
Cell Experiment | |
---|---|
Cell lines | ALL cells |
Preparation method | cell proliferation assay as described previously |
Concentrations | 0~50μM |
Incubation time | 16 h |
Animal Experiment | |
---|---|
Animal models | ALL cells tumour xenograft SCID mice |
Formulation | DMSO |
Dosages | 0.85mg/kg +0.5mg/kg daily |
Administration | i.p. |
Molecular Weight | 294.30 |
Formula | C17H14N2O3 |
CAS Number | 133550-30-8 |
Solubility (25°C) | DMSO ≥45 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
Related JAK Products |
---|
BMS-986202
BMS-986202 is a potent, selective, orally active Tyk2 inhibitor that binds to Tyk2 JH2 with an IC50 of 0.19 nM and a Ki of 0.02 nM. BMS-986202 is also a weak inhibitor of CYP2C19 with an IC50 of 14 μM. BMS-986202 can be used in IL-23-driven echinococcosis BMS-986202 can be used in studies of IL-23-driven echinococcosis, anti-CD40-induced colitis and spontaneous lupus. |
GDC046
GDC046 (Compound 3) is a potent, selective, and orally bioavailable inhibitor of TYK2 with Ki of 4.8 nM, 83.8 nM, 27.6 nM and 253 nM for TYK2, JAK1, JAK2, and JAK3, respectively. |
RO495
RO495 (CS-2667) is a potent inhibitor of Non-receptor tyrosine-protein kinase 2 (TYK2). |
TG-89
TG-89 is a JAK inhibitor that inhibits JAK2, FLT3, RET and JAK3. |
WYE-175765
WYE-175765 is a JAK3 and YopH inhibitor |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.